Nanomedicine for Combination Urologic Cancer Immunotherapy

Urologic cancers, particularly kidney, bladder, and prostate cancer, have a growing incidence and account for about a million annual deaths worldwide. Treatments, including surgery, chemotherapy, radiotherapy, hormone therapy, and immunotherapy are the main therapeutic options in urologic cancers. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Yun, Liu, Zhenzhu, Wang, Jianbo, Li, Linan, Wang, Fuli, Zhu, Zheng, Wang, Xuejian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960671/
https://www.ncbi.nlm.nih.gov/pubmed/36839868
http://dx.doi.org/10.3390/pharmaceutics15020546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960671/
https://www.ncbi.nlm.nih.gov/pubmed/36839868
http://dx.doi.org/10.3390/pharmaceutics15020546

Ejemplares similares